Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
HRTX

Heron Therapeutics

$17.72

0.53 (3.08%)

08:31
08/20/19
08/20
08:31
08/20/19
08:31
Hot Stocks
Heron Therapeutics announces results from EPOCH 2 Phase 3 study of HTX-011 »

Heron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
HRTX

Heron Therapeutics

$16.46

0.09 (0.55%)

07:57
08/06/19
08/06
07:57
08/06/19
07:57
Recommendations
Heron Therapeutics analyst commentary at Jefferies »

Heron Therapeutics shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRTX

Heron Therapeutics

$16.37

-0.76 (-4.44%)

08:32
08/05/19
08/05
08:32
08/05/19
08:32
Earnings
Heron Therapeutics reports Q2 EPS (63c), consensus (64c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
HRTX

Heron Therapeutics

$18.46

0.21 (1.15%)

07:29
06/28/19
06/28
07:29
06/28/19
07:29
Recommendations
Heron Therapeutics analyst commentary at Cowen »

Heron Therapeutics issues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

HRTX

Heron Therapeutics

$17.72

-0.14 (-0.78%)

, PCRX

Pacira

$42.90

0.36 (0.85%)

08:37
05/30/19
05/30
08:37
05/30/19
08:37
Recommendations
Heron Therapeutics, Pacira analyst commentary at Jefferies »

Heron Therapeutics target…

HRTX

Heron Therapeutics

$17.72

-0.14 (-0.78%)

PCRX

Pacira

$42.90

0.36 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 04

    Jun

  • 04

    Jun

Over a quarter ago
HRTX

Heron Therapeutics

$17.82

-0.24 (-1.33%)

09:16
05/21/19
05/21
09:16
05/21/19
09:16
Hot Stocks
Heron Therapeutics announces publication of results from Phase 3 EPOCH 1 »

Heron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

HRTX

Heron Therapeutics

$17.50

-0.48 (-2.67%)

08:32
05/14/19
05/14
08:32
05/14/19
08:32
Hot Stocks
Heron Therapeutics announces results from pain management study with HTX-011 »

Heron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

HRTX

Heron Therapeutics

$16.92

-0.05 (-0.29%)

08:40
05/09/19
05/09
08:40
05/09/19
08:40
Earnings
Breaking Earnings news story on Heron Therapeutics »

Heron Therapeutics backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

HRTX

Heron Therapeutics

$16.92

-0.05 (-0.29%)

08:39
05/09/19
05/09
08:39
05/09/19
08:39
Earnings
Heron Therapeutics reports Q1 EPS (80c), consensus (49c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

PCRX

Pacira

$46.80

-1.17 (-2.44%)

, HRTX

Heron Therapeutics

$16.96

-0.885 (-4.96%)

06:18
05/06/19
05/06
06:18
05/06/19
06:18
Upgrade
Pacira, Heron Therapeutics rating change at Mizuho »

Pacira upgraded to…

PCRX

Pacira

$46.80

-1.17 (-2.44%)

HRTX

Heron Therapeutics

$16.96

-0.885 (-4.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 30

    May

  • 31

    May

  • 04

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.